Lucid Diagnostics

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$4,702,355
$1,211
$1,163
$828
Gross Profit
-1,964,680
-706
-622
-723
EBITDA
-13,802
-11,539
-4,211
-26,678
EBIT
-14,011
-11,759
-4,433
-26,899
Net Income
-70,527,256
-10,397
-4,439
-26,908
Net Change In Cash
4,702,355
1,211
1,163
828
Free Cash Flow
-23,471,000
-10,921
-10,574
-12,558
Cash
34,705,000
47,332
31,123
25,238
Basic Shares
101,947
108,176
98,989
68,796

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$4,706,000
$4,346
$2,428
$377
Gross Profit
-1,964,000
-3,920
-6,050
-3,237
EBITDA
-49,640,000
-44,336
-49,751
-54,235
EBIT
-49,640,872
-45,503
-52,250
-56,171
Net Income
-70,569,000
-45,529
-52,666
-56,171
Net Change In Cash
4,706,000
4,346
2,428
377
Cost of Revenue
-31,182
Free Cash Flow
-46,485,000
-44,786
-33,038
-30,593
Cash
34,705,000
22,358
18,896
22,474
Basic Shares
101,947
50,516
41,756
36,172

Earnings Calls

QuarterEPS
2025-12-31
-$0.10
2025-09-30
-$0.10
2025-06-30
-$0.10
2025-03-31
-$0.16